usbureau nation institut health usbureau doctitl prospect grant exclus licens recombin viru express human carcinoembryon antigen method use thereof doctitl agenc agenc nation institut health public health servic dhh agenc action action notic action summari summari notic accord 35 u c 209 c 1 37 cfr 404 7 1 nation institut health nih depart health human servic contempl grant limit field use exclus licens unit state practic invent embodi u patent applic number 07 695 024 file may 6 1991 07 879 649 file may 6 1992 entitl recombin viru express human carcinoembryon antigen method use thereof therion biolog corpor place busi cambridg patent right invent assign unit state america prospect exclus licens royalti bear compli term condit 35 u c 209 37 cfr 404 7 prospect exclus licens may grant unless within 60 day date publish notic nih receiv written evid argument establish grant licens would consist requir 35 u c 209 37 cfr 404 7 field use would limit use recombin vaccinia swinepox virus express carcinoembryon antigen cea gene portion thereof aim elicit immunogen respons immun respons vivo elicit exposur recombin viru would direct malign cell express cea purpos licens develop vaccinia swine pox viru base vaccin direct cancer express cea request copi patent applic inquiri comment materi relat contempl licens direct mr daniel r passeri offic technolog transfer nation institut health box ott bethesda md 20892 telephon 301 4967735 ext 244 facsimil 301 4020220 properli file compet applic licens file respons notic treat object contempl licens written comment applic licens receiv nih offic technolog transfer within sixti 60 day notic consid date juli 22 1994 summari signer barbara mcgarey signer signjob deputi director offic technolog transfer signjob frfile fr doc 9418826 file 8294 8 45 frfile bill bill code 414001p bill